Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Daniel Gensler
Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After One Year
Clinical Pharmacology and Therapeutics
Pharmacology
Related publications
Pregnancy Outcome After Exposure to Migalastat for Fabry Disease: A Clinical Report
Case Reports in Obstetrics and Gynecology
Strong Increase of Leukocyte Apha‐galactosidase a Activity in Two Male Patients With Fabry Disease Following Oral Chaperone Therapy
Molecular genetics & genomic medicine
Genetics
Molecular Biology
Safety of Switching to Migalastat From Enzyme Replacement Therapy in Fabry Disease: Experience From the Phase 3 ATTRACT Study
American Journal of Medical Genetics, Part A
Genetics
Quantitative Changes of Melanoma-Associated Antigens as a Biomarker for Targeted Therapy Response
Experimental Dermatology
Biochemistry
Dermatology
Molecular Biology
After One Year
International Journal of Plant Biology
Plant Science
After One Year ...
GDR Bulletin
Serum Osteoprotegerin as a Biomarker for Vascular Disease
American Journal of Cardiology
Cardiovascular Medicine
Cardiology
Changes in Deceased Donor Kidney Transplantation One Year After KAS Implementation
American Journal of Transplantation
Transplantation
Allergy
Immunology
Pharmacology
Renal Aspects and Enzyme Replacement Therapy of Fabry Disease